Cardio3

Cardio3 BioSciences is a Belgian biotechnology company aiming to heal heart failure

  • Cardio3 BioSciences floated on Euronext Brussels and Euronext Paris
  • Proceeds of the IPO were dedicated to fund European phase III trials of its flagship product, C-Cure
  • Kempen & Co acted as Sole Global Coordinator and Joint Bookrunner
Disclaimer Kempen & Co Privacy statement Asset Management Privacy statement Merchant Banking Statement under the UK Modern Slavery Act Cookie Settings
Van Lanschot